Main > ONCOLOGY (**) > Prostate Cancer mCRPC PSMA+ > CH. N. Treat.>Radioligand Agent IV>

---

Inj

CH. N. Treat.>Radioligand Agent IV>'s subsections
(*) USA Approval Date: 2022. 03.23
>Diagnostics>Ga 68 Gozetotide IV In
>Previously Treated with AR Inh.>
Company
Generic Name
RTM
RTM Web-Site
USA Patent Numbers

CH. N. Treat.>Radioligand Agent IV>'s products
This section has no products